+44 (0) 20 7079 4399
Call HCA from 8am-8pm Mon-Fri and 9am-5pm Sat
HCA Healthcare UK
Dr Maria Pia Michelagnoli
MD FRCPCH MB ChB
Paediatric Oncology, Bone and/or soft tissue cancers, Cancers in children and/or young persons
Paediatric bone and soft tissue sarcomas (chemotherapy)
Dr Maria Michelagnoli is a trained Paediatrician with sub-specialist recognition in paediatric oncology. Her cancer training was carried out in the Yorkshire Regional Department of Paediatric Oncology and Haematology. She currently works in the Children's and Young People Cancer Service at University College Hospital (CYPCS), site-specialising within the sarcoma service.Dr Michelagnoli completed her MD (University of Leeds) at the Candlelighter's laboratory (CRUK, Leeds) in the application of molecular diagnostics in rhabdomyosarcoma. She currently has a strong interest in clinical trials in sarcoma, acting as principal investigator for a number of national and international trials. She is actively involved in coordinating sarcoma research at a national level as a member of the CCLG Sarcoma working Group, and is a member of the Connective Tissue Oncology Society. She is also a board member of the Teenage and Young Adults with Cancer (TYAC) group - a professional group for specialists in young people's cancer care.Dr Michelagnoli regularly teaches and lectures on the management of sarcomas in children and adolescents, as well as generic lecturing on aspects of adolescent cancer care.
Call the contact centre
+44 (0) 20 7079 4399
8am-8pm Mon-Fri, 9am-5pm Sat
Let us call you backCan we call you back at a more convenient time
Email contact centreSend us an email and we will get back to you.
© copyright 2008 - 2017 HCA Healthcare UK.
Registered Name: HCA International Limited; The part of the UK in which it is registered: England and Wales;
Registered Number: 03020522; Registered Office Address: 242 Marylebone Road London NW1 6JL.
£500m has been invested by HCA International in the latest medical technologies and facilities over the last 10 years.
Your hospital will be one of our world-class private hospitals: HCA’s world-class hospitals are accredited by The CHKS Accreditation Unit, a leading provider of healthcare intelligence and quality improvement services. The accreditation is a measure of the overall quality of a hospital and hospitals with CHKS accreditation have been shown to provide a better quality of service.
Your safety will be protected because we have more critical care beds than any other private hospital group: HCA hospitals achieved 100% compliance with all Care Quality Commission inspected outcomes of care in 2011.
Your treatment will be undertaken using the most advanced diagnostic and treatment facilities: Oliver Wyman, Corporate Accounts: Driving quality and value, January 2012.